Search

Author/Creator Mahmoud, Ramy A.

1. A Randomized, Double‐Blind, Placebo‐Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP‐825) in the Treatment of Acute Migraine (The TARGET Study). Issue 1 (30th October 2014)

Authors:
Cady, Roger K.; McAllister, Peter J.; Spierings, Egilius L.H.; Messina, John; Carothers, Jennifer; Djupesland, Per G.; Mahmoud, Ramy A.
Journal:
Headache
Issue:
Volume 55:Issue 1(2015)
Page Start:
88
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. AVP‐825 Breath‐Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks. Issue 5 (4th May 2015)

Authors:
Tepper, Stewart J.; Cady, Roger K.; Silberstein, Stephen; Messina, John; Mahmoud, Ramy A.; Djupesland, Per G.; Shin, Paul; Siffert, Joao
Journal:
Headache
Issue:
Volume 55:Issue 5(2015)
Page Start:
621
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP‐825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan. Issue 6 (11th May 2017)

Authors:
Silberstein, Stephen; Winner, Paul K.; McAllister, Peter J.; Tepper, Stewart J.; Halker, Rashmi; Mahmoud, Ramy A.; Siffert, Joao
Journal:
Headache
Issue:
Volume 57:Issue 6(2017)
Page Start:
862
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. EDS‐FLU: An important step in appropriate medical therapy for chronic rhinosinusitis with nasal polyps. Issue 6 (17th April 2022)

Authors:
Leopold, Donald A.; Elkayam, David; Han, Joseph K.; Soteres, Daniel F.; Messina, John C.; Carothers, Jennifer L.; Sacks, Harry J.; Mahmoud, Ramy A.; Djupesland, Per G.; Sindwani, Raj
Journal:
International forum of allergy & rhinology
Issue:
Volume 12:Issue 6(2022)
Page Start:
893
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy of the exhalation delivery system with fluticasone in patients with chronic rhinosinusitis with nasal polyps whose symptoms recur after sinus surgery. Issue 1 (26th June 2022)

Authors:
Ow, Randall A.; Soler, Zachary M.; Sindwani, Raj; Leopold, Donald A.; Lee, Jivianne T.; Mahmoud, Ramy A.; Han, Joseph K.
Journal:
International forum of allergy & rhinology
Issue:
Volume 13:Issue 1(2023)
Page Start:
31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial. (July 2016)

Authors:
Quintana, Daniel S.; Westlye, Lars T.; Alnæs, Dag; Rustan, Øyvind G.; Kaufmann, Tobias; Smerud, Knut T.; Mahmoud, Ramy A.; Djupesland, Per G.; Andreassen, Ole A.
Journal:
Psychoneuroendocrinology
Issue:
Volume 69(2016:Jul.)
Page Start:
180
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps. Issue 1 (January 2019)

Authors:
Sindwani, Raj; Han, Joseph K.; Soteres, Daniel F.; Messina, John C.; Carothers, Jennifer L.; Mahmoud, Ramy A.; Djupesland, Per G.
Journal:
American journal of rhinology & allergy
Issue:
Volume 33:Issue 1(2019)
Page Start:
69
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗